New device aims to reduce heart transplant complications
NCT ID NCT07230886
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study tests a new temperature control system (Xo Port) for preserving donor hearts during transplant, compared to the standard ice method. The goal is to see if it reduces severe complications like primary graft dysfunction. About 50 adult heart transplant recipients will take part, and researchers will track outcomes like survival, recovery time, and organ function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY GRAFT DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health Network
RECRUITINGToronto, Ontario, M5G 2C4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.